Fairvalue-Calculator Fairvalue-Calculator

Guangxi LiuYao Group (603368) Fair Value & Analysis

Healthcare · CN · Market cap 6.6B CNY

Price¥15.52
Fair Value¥39.29
Upside+153.2%
Quality93/100
Evidence: High Range ¥29.47 – ¥49.12

Analysis

Guangxi LiuYao Group (603368) currently trades at ¥15.52, while our model-based Fair Value estimate is ¥39.29 — implying the stock looks roughly 153.2% undervalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It offers various types of medicines, medical devices, consumables, and test reagents through online pharmacies and terminal physical pharmacies. The company was founded in 1981 and is based in Liuzhou, China.

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) -81% Cencora, Inc (C1CO34) -89% Cardinal Health, Inc (CAH) -38% Sigma Healthcare Limited (SIGGF) -73% Sitka Gold Corp (SIG) -88% Shanghai Pharmaceuticals Holding (601607) +183%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.